Report Categories
View AllRecent Articles
View All
Gilead Sciences GILD Pipeline Milestones and Arcellx Acquisition Reinforce LongTerm Growth Trajectory in HIV and Oncology
ENSC Ensysce Biosciences reports narrower Q4 2025 loss than estimates shares climb after earnings release
NNAVW NextNav market participants await quarterly earnings to gauge its core geolocation business growth momentum
What EQV EVAC does that creates lasting value Steady 20260503